New drug development.
作者信息
Taylor W J
出版信息
Int Z Klin Pharmakol Ther Toxikol. 1969 Apr;2(2):105-13.
PMID:4895441
Abstract
摘要
相似文献
1
New drug development.新药研发
Int Z Klin Pharmakol Ther Toxikol. 1969 Apr;2(2):105-13.
2
Reading our lips: the history of lipstick regulation in Western seats of power.解读我们的唇妆：西方权力中心口红监管的历史
Food Drug Law J. 2007;62(1):165-225.
3
[On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation].[从药物立法角度看反应停（沙利度胺）灾难的历史]
Dtsch Med Wochenschr. 2001 Oct 19;126(42):1183-6. doi: 10.1055/s-2001-17888.
4
[Status of side effects. 2. Adverse effects from a historical point of view. Classic examples].
Tidsskr Nor Laegeforen. 1989 Nov 10;109(31):3225-6.
5
The relationships of the American Society for Clinical Pharmacology and Therapeutics to government.美国临床药理学与治疗学协会与政府的关系。
Clin Pharmacol Ther. 1990 Feb;47(2):287-90.
6
Food and Drug Administration: 100 years of protection.美国食品药品监督管理局：100年的保护历程。
Home Healthc Nurse. 2007 Mar;25(3):148-50. doi: 10.1097/01.NHH.0000263429.92814.55.
7
Learning about the safety of drugs--a half-century of evolution.了解药物安全性——半个世纪的演变
N Engl J Med. 2011 Dec 8;365(23):2151-3. doi: 10.1056/NEJMp1110327.
8
[Teratogenic effect of drugs].[药物的致畸作用]
Gynakologe. 1982 Sep;15(3):136-42.
9
Drug development history, "overview," and what are GCPs?药物研发历史、“概述”以及什么是药物临床试验规范？
Qual Assur. 1995 Mar;4(1):75-9.
10
Some therapeutic disasters and their repercussions.
Med Ann Dist Columbia. 1967 Feb;36(2):81-7.
Zotero 插件